BRPI1012211A2 - lactoferrina e desenvolvimento e saúde cerebral em crianças - Google Patents

lactoferrina e desenvolvimento e saúde cerebral em crianças

Info

Publication number
BRPI1012211A2
BRPI1012211A2 BRPI1012211A BRPI1012211A BRPI1012211A2 BR PI1012211 A2 BRPI1012211 A2 BR PI1012211A2 BR PI1012211 A BRPI1012211 A BR PI1012211A BR PI1012211 A BRPI1012211 A BR PI1012211A BR PI1012211 A2 BRPI1012211 A2 BR PI1012211A2
Authority
BR
Brazil
Prior art keywords
lactoferrin
children
health
brain development
brain
Prior art date
Application number
BRPI1012211A
Other languages
English (en)
Inventor
Bing Wang
Jeroen Antonius Johannes Schmitt
Magali Faure
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI1012211A2 publication Critical patent/BRPI1012211A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40Transferrins, e.g. lactoferrins, ovotransferrins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C19/00Cheese; Cheese preparations; Making thereof
    • A23C19/02Making cheese curd
    • A23C19/05Treating milk before coagulation; Separating whey from curd
    • A23C19/053Enrichment of milk with whey, whey components, substances recovered from separated whey, isolated or concentrated proteins from milk
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/152Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/1526Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/205Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey from whey, e.g. lactalbumine
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pediatric Medicine (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI1012211A 2009-05-12 2010-05-07 lactoferrina e desenvolvimento e saúde cerebral em crianças BRPI1012211A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09159966A EP2251030A1 (en) 2009-05-12 2009-05-12 Lactoferrin and brain health and development in infants
PCT/EP2010/056237 WO2010130643A1 (en) 2009-05-12 2010-05-07 Lactoferrin and brain health and development in infants

Publications (1)

Publication Number Publication Date
BRPI1012211A2 true BRPI1012211A2 (pt) 2016-04-05

Family

ID=41119265

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1012211A BRPI1012211A2 (pt) 2009-05-12 2010-05-07 lactoferrina e desenvolvimento e saúde cerebral em crianças

Country Status (13)

Country Link
US (1) US8524658B2 (pt)
EP (2) EP2251030A1 (pt)
JP (1) JP2012526746A (pt)
CN (2) CN102458450B (pt)
BR (1) BRPI1012211A2 (pt)
CA (1) CA2761480A1 (pt)
ES (1) ES2715282T3 (pt)
MX (1) MX343325B (pt)
MY (1) MY183291A (pt)
RU (2) RU2568596C2 (pt)
TW (1) TW201106966A (pt)
WO (1) WO2010130643A1 (pt)
ZA (1) ZA201109089B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8498729B2 (en) * 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
EP2251032A1 (en) * 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and brain health and protection in adults
EP2251031A1 (en) * 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and neuronal health and development in the infant gut
US8968722B2 (en) 2010-12-29 2015-03-03 Mead Johnson Nutrition Company Milk-based nutritional compositions containing lactoferrin and uses thereof
AU2012273206B2 (en) 2011-06-20 2015-09-24 H.J. Heinz Company Brands Llc Probiotic compositions and methods
MX350435B (es) 2011-10-18 2017-09-06 Nestec Sa Composicion para uso en el crecimiento del cerebro y/o desarrollo cognitivo y/o desarrollo psicomotor.
PL2594282T3 (pl) * 2011-11-21 2015-01-30 Nestec Sa Laktoferyna i istota biała
EP2609814A1 (en) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of cognitive function
RU2517162C2 (ru) * 2012-09-24 2014-05-27 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский институт акушерства и педиатрии" Министерства здравоохранения и социального развития Российской Федерации Способ профилактики перинатального поражения центральной нервной системы новорожденных детей
ITMI20122152A1 (it) 2012-12-17 2014-06-18 Progine Farmaceutici S R L Composizione per uso topico.
ES2672194T3 (es) * 2012-12-18 2018-06-13 Mjn U.S. Holdings Llc Composiciones nutricionales a base de leche que contienen lactoferrina y sus usos
MX2013003636A (es) * 2013-03-27 2014-09-29 Palsgaard Ind De Mexico S De R L De C V Complemento alimenticio para personas con trisomia 21, transtorno del espectro autista y/o transtorno por deficit de atencion con o sin hiperactividad.
US9226914B2 (en) 2013-07-16 2016-01-05 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
US9241923B2 (en) * 2013-07-16 2016-01-26 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
US10709770B2 (en) 2013-07-31 2020-07-14 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US9609888B2 (en) * 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
CN105492018A (zh) * 2013-09-02 2016-04-13 雀巢产品技术援助有限公司 乳铁蛋白和儿童的记忆和学习速度
MX2016001225A (es) * 2013-09-02 2016-05-24 Nestec Sa Lactoferrina y memoria y velocidad de aprendizaje en niños.
US10517918B2 (en) 2013-12-13 2019-12-31 Societe Des Produits Nestle S.A. Use of a modified sweet whey and a modified sweet whey containing infant formula for promoting the postnatal development of the infant central nervous system and related cognitive functions
US20150305385A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
EP2992894A1 (en) 2014-09-05 2016-03-09 Progine Farmaceutici Srl Vaginal formulations for preventing and treating vaginal and cervico-vaginal infections
PL235821B1 (pl) * 2014-11-04 2020-11-02 Geo Poland Spolka Z Ograniczona Odpowiedzialnoscia Wysokoprolinowy kompleks peptydowy do zastosowania w profilaktyce i wspomaganiu leczenia zaburzeń i stanów wymagających podwyższania i/lub modulacji poziomu neurotropowego czynnika pochodzenia mózgowego jako oznaczonego w osoczu krwi biomarkera i zawierający go preparat
CN107072282A (zh) * 2014-11-07 2017-08-18 Mjn 美国控股有限责任公司 包含益生元和乳铁蛋白的营养组合物及其应用
US10582714B2 (en) 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US10617701B2 (en) 2015-07-10 2020-04-14 Mead Johnson Nutrition Company Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
WO2017194068A1 (en) 2016-05-12 2017-11-16 Arla Foods Amba Whey preparation for improving brain development
US11197917B2 (en) * 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
CN109007037B (zh) * 2018-10-16 2022-02-18 北京斯利安药业有限公司 一种增强婴幼儿免疫力的组合物及其产品与应用
CN112493494A (zh) * 2019-09-16 2021-03-16 谢驰南 含有乳铁蛋白和唾液酸的组合物及其制备方法和用途
JP2021171059A (ja) * 2020-04-21 2021-11-01 サンスター株式会社 遂行機能改善用組成物
CN118285505A (zh) * 2024-03-29 2024-07-05 黑龙江飞鹤乳业有限公司 促进大脑发育的营养组合物、食品及配方奶粉

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2000A (en) * 1841-03-12 Improvement in the manufacture of starch
US7000A (en) * 1850-01-08 Smut-machine
EP0322589B1 (fr) 1987-12-23 1993-01-20 Societe Des Produits Nestle S.A. Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques
JP2660908B2 (ja) * 1995-02-24 1997-10-08 森永乳業株式会社 ビフィズス菌増殖促進性及び生残性が良好なヨーグルト
CA2233848A1 (en) * 1995-10-17 1997-04-24 The Regents Of The University Of California Methods of reducing apolipoprotein e4-induced inhibition of neuron remodeling
EP0880902A1 (fr) 1997-05-27 1998-12-02 Nestlé Produkte AG Procédé de traitement d'une matiére première lactosérique
US6489375B2 (en) * 1998-07-07 2002-12-03 Sun Chemical Corporation Low VOC cationic curable lithographic printing inks
US6258383B1 (en) * 1998-08-14 2001-07-10 Lactoferrin Products Company Dietary supplement combining colostrum and lactoferrin in a mucosal delivery format
PL199861B1 (pl) 1999-04-29 2008-11-28 Nestle Sa Preparat dla niemowląt i sposób wytwarzania preparatu
DK1480524T3 (da) * 2002-03-07 2013-07-15 Upfront Chromatography As Fremgangsmåde til isolering af lactoferrin
JP4452569B2 (ja) * 2004-06-29 2010-04-21 有限会社フードデザイン健康研究所 桃の花及びラクトフェリンを主成分とする食品
WO2007145520A1 (en) * 2006-06-14 2007-12-21 N.V. Nutricia Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof
WO2007145220A1 (ja) 2006-06-14 2007-12-21 Panasonic Corporation 書き換え可能な回路を備える装置、更新システム、更新方法、更新プログラム、及び集積回路
US20080003330A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
ITRM20060434A1 (it) * 2006-08-07 2008-02-08 Pietro Raimondi Prodotto da somministrare all organismo umano per isuoi effetti protettivi e curativi a base di latte di bufala autorricchito di lattoferrina oppure di lattoferrina tal quale ottenuto attraverso processi separativi di membrana
CN101279866B (zh) 2007-12-05 2011-01-05 朱庆然 大颗粒尿素或颗粒复合肥硫胞衣智能膜制备方法
CN101278688A (zh) * 2008-05-22 2008-10-08 澳大利亚迪唯恩乳业有限公司 婴幼儿营养免疫配方奶粉及其生产方法

Also Published As

Publication number Publication date
MY183291A (en) 2021-02-18
TW201106966A (en) 2011-03-01
EP2429572A1 (en) 2012-03-21
US8524658B2 (en) 2013-09-03
EP2429572B1 (en) 2018-12-19
CN102458450A (zh) 2012-05-16
RU2011150194A (ru) 2013-06-20
RU2015141812A (ru) 2018-12-28
RU2015141812A3 (pt) 2019-03-26
CN105435214B (zh) 2018-12-14
US20120184484A1 (en) 2012-07-19
CA2761480A1 (en) 2010-11-18
MX2011012073A (es) 2012-02-23
CN105435214A (zh) 2016-03-30
RU2688671C2 (ru) 2019-05-22
WO2010130643A1 (en) 2010-11-18
CN102458450B (zh) 2016-01-13
JP2012526746A (ja) 2012-11-01
RU2568596C2 (ru) 2015-11-20
MX343325B (es) 2016-11-01
EP2251030A1 (en) 2010-11-17
ZA201109089B (en) 2013-07-31
ES2715282T3 (es) 2019-06-03

Similar Documents

Publication Publication Date Title
BRPI1012211A2 (pt) lactoferrina e desenvolvimento e saúde cerebral em crianças
BRPI1012147A2 (pt) lactoferrina e saúde e proteção do cérebro em adultos
BRPI1010799A2 (pt) lactoferrina e saúde neuronal e desenvolvimento no intestino infantil
BRPI1013013A2 (pt) "composição nutricional para suporte do desenvolvimento cerebral e função de criança"
BRPI1013020A2 (pt) "composição nutricional para suporte do desenvolvimento cerebral e função de crianças de 0 a 3 anos de idade"
BRPI1011089A2 (pt) Composição nutricional para estimular o desenvolvimento e a função cerebral de crianças.
BR112013013699A2 (pt) fixação de barra de exercícios e método
BRPI0812982A2 (pt) Resinas amina-aldeído modificadas e seus usos em processos de separação
BRPI0907530A2 (pt) Anticorpos direcionados à angiopoietina-1 angiopoietina-2 e seus usos
IL229885B (en) Personalized nutritional and wellness assistant
SG2014010995A (en) Animal models and therapeutic molecules
BRPI0812979A2 (pt) Resinas amina-aldeído e seus usos em processos de separação
HRP20190109T1 (hr) Ljudska antitijela na gfr 3 i načini za njihovu primjenu
DK2408311T3 (da) Valle- eller råmælksdemineralisering og -fraktionering
BR112013024959A2 (pt) sn-1(3) monoacilglicerídeos e absorção de lipídeo
BRPI0809901A2 (pt) Produto absorvente com sinalizador sonoro e método para aumentar o volume percebido
BR112013014005A2 (pt) resina-em-lixiviação cocorrente e contracorrente em processos de lixiviação de ouro
BRPI1012696A2 (pt) composicao nutricional compreendendo curminaoides e metodos de fabricacao
GB0817306D0 (en) Improvements in or relating to baby care
BR112014015092A2 (pt) produto absorvente descartável com regiões de abertura elástica na perna elástica e métodos relacionados
PT2670769T (pt) R2r1/2 em diagnóstico e terapêutica
GB2501736B (en) Infant bed frame assembly and child bed assembly
DE602009001104D1 (de) Kindersitz
GB0814657D0 (en) Compsoitions and methods for maintaining lipid health
ES1071307Y (es) Carreton para entrenamiento en practicas de acoso-derribo y rejoneo

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 38/40 (2006.01), A23L 33/19 (2016.0

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2513 DE 06-03-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.